H.Con.Res. 42 · 117th Congress
Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.
- Stage
- In committee
- Sponsor
- David McKinley
- Introduced
- 2021-07-21
- Latest action
- 2021-07-22 · Referred to the Subcommittee on Health.
Summary
This concurrent resolution expresses the sense of Congress that government entities should consider using a portion of proceeds from litigation against opioid manufacturers and distributors for drug take-back programs.